Biocon Biologics Acquires Viatris Biosimilars
Biocon Biologics acquired Viatris Biosimilars for $3.3B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Biocon Biologics
- Acquired Company
- Viatris Biosimilars
- Price
- $3.3B
- Acquisition Type
- Acquisition
- Announced
- February 28, 2021
Canonical: https://fsome.com/acquisitions/biocon-biologics-acquires-viatris-biosimilars-8168413 · For the full deal terms, timeline, and press references, please enable JavaScript.